October 5, 2010 — A landmark breast cancer screening study of women 40­-49 years of age, published online in Cancer, has proven that annual mammography screening of women in their 40s reduces the breast cancer death rate in these women by nearly 30 percent. The results of the largest study ever conducted on women in this age group confirm that the use of the age of 50 as a threshold for breast cancer screening is scientifically unfounded. Women should begin getting annual mammograms at age 40.

“This study, which looked at the performance of screening mammography as it is actually used, rather than relying on mathematical modeling, shows without a doubt that mammography decreases deaths from breast cancer in women aged 40-49 by nearly one third. There is no excuse not to recommend that average risk women begin annual screening mammography at age 40,” said Carol H. Lee, M.D., chair of the American College of Radiology breast imaging commission.

In November of 2009, the United States Preventive Services Task Force (USPSTF) ignored published data showing a similar death rate reduction to this landmark trial and withdrew support for screening women 40-­49. This study is more robust and based on real-world numbers, and proves that the benefit is nearly twice that of the USPSTF estimate of 15 percent.

The Swedish trial followed more than 600,000 women for 16 years. The number of breast cancer deaths among the women in the study who did not receive mammograms was twice as high as those who underwent screening.

For more information: http://onlinelibrary.wiley.com/doi/10.1002/cncr.25650/abstract


Related Content

News | Ultrasound Imaging

Oct. 19, 2026 – GE HealthCare has introduced LOGIQ Focus, a new addition to its LOGIQ family of general imaging ...

Time October 19, 2026
arrow
News | Breast Imaging

Oct. 6, 2026 — The American College of Radiology (ACR) has recognized Mercy Medical Center’s Tyanna O’Brien Center for ...

Time October 09, 2026
arrow
News | Artificial Intelligence

Oct. 7, 2026 – CARPL.ai has announced a collaboration with HOPPR that will give healthcare providers access to HOPPR's ...

Time October 08, 2026
arrow
News | ASTRO

Oct. 5, 2026 — The American Society for Radiation Oncology (ASTRO) recognized the recipients of its 2026 Gold Medal ...

Time October 07, 2026
arrow
Feature | Digital Pathology | Kyle Hardner

As recently as a decade ago, pathology technology was expected to become more expensive, larger and more precise. Yet in ...

Time October 02, 2026
arrow
News | Artificial Intelligence

Sept. 29, 2026 — A recently published study shows that using artificial intelligence to track which pathologies ...

Time October 01, 2026
arrow
News | Ultrasound Women's Health

Sept. 29, 2026 — A research team at the University of Virginia (UVA) led by Timothy Bullock, PhD, has published results ...

Time September 30, 2026
arrow
News | ASTRO

Sept. 29, 2026 — The American Society for Radiation Oncology (ASTRO) has named Siemens Healthineers the inaugural ...

Time September 29, 2026
arrow
News | Proton Therapy

Sept. 28, 2026 — Penn Medicine and Ion Beam Applications (IBA) have formed Noventra Oncology Alliance, a new joint ...

Time September 28, 2026
arrow
News | ASTRO

Sept. 22, 2026 — Leading experts in radiation therapy from the Abramson Cancer Center (ACC) of the University of ...

Time September 24, 2026
arrow
Subscribe Now